Literature DB >> 7279783

Malignant histiocytosis presenting as lethal midline granuloma.

K Aozasa, Y Watanabe, H Ikeda.   

Abstract

The clinical and histologic materials, including autopsy findings, from 6 cases with clinical features of so-called lethal midline granuloma were examined. These cases were selected by characteristic biopsy findings observed in the nasal lesions. The histologic features of the nasal lesions were necrosis and infiltration of atypical histiocytic cells. The mean age was 37 years with a 2:1 male to female preponderance. Nasal complaints and fever were frequent manifestation, and physical findings showed necrotic, granulomatous lesions in the nasal cavity in all cases. The survival ranged from 4 to 24 months, giving a mean value of 13 months. Autopsy findings revealed systemic, neoplastic proliferation of atypical histiocytes, from these observation, these 6 cases should be regarded as malignant histiocytosis (MH) with usual presentation.

Entities:  

Mesh:

Year:  1981        PMID: 7279783     DOI: 10.1016/S0344-0338(81)80104-5

Source DB:  PubMed          Journal:  Pathol Res Pract        ISSN: 0344-0338            Impact factor:   3.250


  4 in total

1.  Heterogeneous malignant non Hodgkin's lymphomas as a causative disorder in lethal midline granuloma.

Authors:  R H Laeng; H A Gerber; T Schaffner; K H Bürki
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1989

2.  Biopsy findings in malignant histiocytosis presenting as lethal midline granuloma.

Authors:  K Aozasa
Journal:  J Clin Pathol       Date:  1982-06       Impact factor: 3.411

3.  Villous atrophy with crypt hyperplasia in malignant histiocytosis of the nose.

Authors:  K Aozasa
Journal:  J Clin Pathol       Date:  1982-06       Impact factor: 3.411

Review 4.  Nasal NK/T-cell lymphoma: epidemiology and pathogenesis.

Authors:  Katsuyuki Aozasa; Tetsuya Takakuwa; Tadashi Hongyo; Woo-Ick Yang
Journal:  Int J Hematol       Date:  2008-02-08       Impact factor: 2.490

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.